SABRTooth: A randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection

Kevin N. Franks, Lucy McParland, Joanne Webster, David R. Baldwin, David Sebag-Montefiore, Matthew Evison, Richard Booton, Corinne Faivre-Finn, Babu Naidu, Jonathan Ferguson, Clive Peedell, Matthew E.J. Callister, Martyn Kennedy, Jenny Hewison, Janine Bestall, Walter M. Gregory, Peter Hall, Fiona Collinson, Catherine Olivier, Rachel NaylorSue Bell, Peter Allen, Andrew Sloss, Michael Snee

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'SABRTooth: A randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection'. Together they form a unique fingerprint.

Medicine and Dentistry